Trail-blazing social entrepreneurs are tackling the world’s most pressing problems that government, business, or charity have failed to solve. They are creating businesses with a primary mission of social change. Scott Boyer is one such social entrepreneur.
Trail-blazing social entrepreneurs are tackling the world’s most pressing problems that government, business, or charity have failed to solve. They are creating businesses with a primary mission of social change. Scott Boyer is one such social entrepreneur.
Trail-blazing social entrepreneurs are tackling the world’s most pressing problems that government, business, or charity have failed to solve. They are creating businesses with a primary mission of social change. Scott Boyer is one such social entrepreneur. This 28-year veteran of Big Pharma left a six-figure salary to start OWP Pharmaceuticals and the ROW Foundation. This commercial business and non-profit organization exist in a symbiotic relationship we call a "tandem hybrid social enterprise." This model combines a multimillion dollar business with a foundation that’s on track to become the largest funder of projects serving people with epilepsy and associated psychiatric disorders in the world.
The tandem hybrid incorporates the principles learned by Scott and others for building a truly unique social enterprise from the ground up; one that is:
Powering Social Enterprises With Profit And Purpose offers a detailed blueprint that has proven commercially and philanthropically successful and that can be replicated in most business sectors.
SCOTT BOYER is the Founder and CEO of OWP Pharmaceuticals and the Founder and Chairman of the ROW Foundation.
JEREMY GUDAUSKAS taught social entrepreneurship at North Central College in Naperville, Illinois where he founded the Center for Social Impact.
MIKE HAMEL has helped more than 100 entrepreneurs and C-level business men and women share their stories with a wider audience.
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.